Log In
Print
BCIQ
Print
Print this Print this
 

basal insulin peglispro (LY2605541)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionOnce-daily basal insulin analog
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes; Treat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today